144 related articles for article (PubMed ID: 17352933)
1. Abnormal cortical synaptic plasticity in a mouse model of Huntington's disease.
Cummings DM; Milnerwood AJ; Dallérac GM; Vatsavayai SC; Hirst MC; Murphy KP
Brain Res Bull; 2007 Apr; 72(2-3):103-7. PubMed ID: 17352933
[TBL] [Abstract][Full Text] [Related]
2. Impaired long-term potentiation in the prefrontal cortex of Huntington's disease mouse models: rescue by D1 dopamine receptor activation.
Dallérac GM; Vatsavayai SC; Cummings DM; Milnerwood AJ; Peddie CJ; Evans KA; Walters SW; Rezaie P; Hirst MC; Murphy KP
Neurodegener Dis; 2011; 8(4):230-9. PubMed ID: 21282937
[TBL] [Abstract][Full Text] [Related]
3. Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease.
Cummings DM; Milnerwood AJ; Dallérac GM; Waights V; Brown JY; Vatsavayai SC; Hirst MC; Murphy KP
Hum Mol Genet; 2006 Oct; 15(19):2856-68. PubMed ID: 16905556
[TBL] [Abstract][Full Text] [Related]
4. Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease.
Milnerwood AJ; Cummings DM; Dallérac GM; Brown JY; Vatsavayai SC; Hirst MC; Rezaie P; Murphy KP
Hum Mol Genet; 2006 May; 15(10):1690-703. PubMed ID: 16600988
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease.
Nithianantharajah J; Hannan AJ
Neuroscience; 2013 Oct; 251():66-74. PubMed ID: 22633949
[TBL] [Abstract][Full Text] [Related]
6. Depletion of Complexin II does not affect disease progression in a mouse model of Huntington's disease (HD); support for role for complexin II in behavioural pathology in a mouse model of HD.
Glynn D; Reim K; Brose N; Morton AJ
Brain Res Bull; 2007 Apr; 72(2-3):108-20. PubMed ID: 17352934
[TBL] [Abstract][Full Text] [Related]
7. Altered distribution of striatal activity-dependent synaptic plasticity in the 3-nitropropionic acid model of Huntington's disease.
Dalbem A; Silveira CV; Pedroso MF; Breda RV; Werne Baes CV; Bartmann AP; da Costa JC
Brain Res; 2005 Jun; 1047(2):148-58. PubMed ID: 15901483
[TBL] [Abstract][Full Text] [Related]
8. A similar impairment in CA3 mossy fibre LTP in the R6/2 mouse model of Huntington's disease and in the complexin II knockout mouse.
Gibson HE; Reim K; Brose N; Morton AJ; Jones S
Eur J Neurosci; 2005 Oct; 22(7):1701-12. PubMed ID: 16197510
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models.
Li W; Silva HB; Real J; Wang YM; Rial D; Li P; Payen MP; Zhou Y; Muller CE; Tomé AR; Cunha RA; Chen JF
Neurobiol Dis; 2015 Jul; 79():70-80. PubMed ID: 25892655
[TBL] [Abstract][Full Text] [Related]
10. Modeling brain reserve: experience-dependent neuronal plasticity in healthy and Huntington's disease transgenic mice.
Nithianantharajah J; Barkus C; Vijiaratnam N; Clement O; Hannan AJ
Am J Geriatr Psychiatry; 2009 Mar; 17(3):196-209. PubMed ID: 19454847
[TBL] [Abstract][Full Text] [Related]
11. Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease.
Hannan AJ
Acta Biochim Pol; 2004; 51(2):415-30. PubMed ID: 15218539
[TBL] [Abstract][Full Text] [Related]
12. Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.
André VM; Cepeda C; Venegas A; Gomez Y; Levine MS
J Neurophysiol; 2006 Apr; 95(4):2108-19. PubMed ID: 16381805
[TBL] [Abstract][Full Text] [Related]
13. Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice.
Nithianantharajah J; Barkus C; Murphy M; Hannan AJ
Neurobiol Dis; 2008 Mar; 29(3):490-504. PubMed ID: 18165017
[TBL] [Abstract][Full Text] [Related]
14. Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutation.
Wade A; Jacobs P; Morton AJ
Brain Res; 2008 Jan; 1188():61-8. PubMed ID: 18062944
[TBL] [Abstract][Full Text] [Related]
15. Impaired development of cortico-striatal synaptic connectivity in a cell culture model of Huntington's disease.
Buren C; Parsons MP; Smith-Dijak A; Raymond LA
Neurobiol Dis; 2016 Mar; 87():80-90. PubMed ID: 26711622
[TBL] [Abstract][Full Text] [Related]
16. Changes in Dopamine Signalling Do Not Underlie Aberrant Hippocampal Plasticity in a Mouse Model of Huntington's Disease.
Dallérac GM; Cummings DM; Hirst MC; Milnerwood AJ; Murphy KP
Neuromolecular Med; 2016 Mar; 18(1):146-53. PubMed ID: 26782175
[TBL] [Abstract][Full Text] [Related]
17. Gene-environment interactions, neuronal dysfunction and pathological plasticity in Huntington's disease.
van Dellen A; Grote HE; Hannan AJ
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1007-19. PubMed ID: 16445565
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and neuropsychological characteristics of Huntington's disease: a review].
Arango-Lasprilla JC; Iglesias-Dorado J; Lopera F
Rev Neurol; 2003 Oct 16-31; 37(8):758-65. PubMed ID: 14593636
[TBL] [Abstract][Full Text] [Related]
19. Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load.
Milnerwood AJ; Raymond LA
J Physiol; 2007 Dec; 585(Pt 3):817-31. PubMed ID: 17947312
[TBL] [Abstract][Full Text] [Related]
20. Corticostriatal synaptic plasticity alterations in the R6/1 transgenic mouse model of Huntington's disease.
Ghiglieri V; Campanelli F; Marino G; Natale G; Picconi B; Calabresi P
J Neurosci Res; 2019 Dec; 97(12):1655-1664. PubMed ID: 31498496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]